CytomX Therapeutics to Participate in Upcoming Healthcare Conferences
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company […]
Royalty Pharma Declares Third-Quarter 2020 Dividend
NEW YORK, Sept. 02, 2020 (GLOBE NEWSWIRE) — The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved […]
Otonomy to Participate in Four Upcoming Investor Conferences
SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative […]
Primoris Services Corporation Announces Heavy Civil Awards Valued Over $76 Million
DALLAS, Sept. 02, 2020 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) today announced two […]
Key Publication of Clinical Study Demonstrates Unyvero Lower Respiratory Tract (LRT) Panel is Likely to Alter Antibiotic Management of Significant Numbers of Patients Presenting with Suspected Pneumonia
Significant number of de-escalations (65.9%) could be made with high degree of clinical confidence when MRSA or Pseudomonas aeruginosa is […]
Mastercard Selects Rekor Systems to Enable Touchless Economy
COLUMBIA, Md., Sept. 02, 2020 (GLOBE NEWSWIRE) — Rekor Systems, Inc, (REKR) (“Rekor”) (the “Company”) a Maryland-based company providing real-time […]
Immunovant Announces Pricing of Public Offering
NEW YORK, Sept. 02, 2020 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT) today announced the pricing of its underwritten public […]
AlloVir Reports Second Quarter 2020 Financial Results
CAMBRIDGE, Mass., Sept. 02, 2020 (GLOBE NEWSWIRE) — AlloVir (Nasdaq: ALVR), a late clinical-stage cell therapy company, today reported financial […]
XOMA to Present at Upcoming Investor Conferences
EMERYVILLE, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) — XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, […]
Progenity to Participate in Two Upcoming Investor Conferences
SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record […]
